Stock VYNE VYNE THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Estimates Revisions VYNE Therapeutics Inc.

Equities

VYNE

US92941V3087

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 04:00:00 2025-01-13 pm EST 		5-day change 1st Jan Change
3.020 USD -11.95% Intraday chart for VYNE Therapeutics Inc. -12.72% -9.85%
Jan. 06 VYNE Therapeutics Completes Enrollment in Phase 2B Trial Evaluating Vyn201 for the Treatment of Nonsegmental Vitiligo CI
Dec. 23 VYNE Therapeutics Reports 'Positive' Phase 1a Results for VYN202 Inhibitor MT

Turnover - Evolution of Analysts' Estimates

estimates-change-chart VYNE-THERAPEUTICS-INC

Earnings Per Share (EPS) - Evolution of Analysts' Estimates

estimates-change-chart VYNE-THERAPEUTICS-INC

EBIT - Evolution of Analysts' Estimates

estimates-change-chart VYNE-THERAPEUTICS-INC

Add to a list
Add to a list

0 selected

To use this feature you must be a member
Log inSign up
 1m. EPS revision 1m. Revenue rev. 1y. EPS revision 1y. Revenue rev.
VYNE THERAPEUTICS INC. Stock VYNE Therapeutics Inc.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
ARGENX SE Stock argenx SE
BIONTECH SE Stock BioNTech SE
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
BEIGENE, LTD. Stock BeiGene, Ltd.
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
GENMAB A/S Stock Genmab A/S
SUMMIT THERAPEUTICS INC. Stock Summit Therapeutics Inc.
 - - -
Average
Weighted average by Cap.
See all sector revisions

Turnover

revisions-chart VYNE-THERAPEUTICS-INC

Earnings Per Share (EPS)

revisions-chart VYNE-THERAPEUTICS-INC

EBIT

revisions-chart VYNE-THERAPEUTICS-INC
  1. Stock Market
  2. Equities
  3. VYNE Stock
  4. Consensus VYNE Therapeutics Inc.
  5. Estimates Revisions